← Evidence map

ArticleClinical and translational medicine2022

Role of lncSLCO1C1 in gastric cancer progression and resistance to oxaliplatin therapy.

Yu-Feng Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

13 papers cite it

2022
2023
2024
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35474446